Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2025 08:00 ET | Source: UroGen Pharma Ltd.

UroGen Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 7th, 2025

Conference Call and Webcast Scheduled for Thursday, August 7th, 2025, at 10:00 AM ET PRINCETON, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company...
July 28, 2025 08:00 ET | Source: UroGen Pharma Ltd.

UroGen Announces Publication of Phase 3b Study Results Demonstrating the Feasibility of Home Instillation of ZUSDURI™ for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer in Reviews in Urology

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty...
July 21, 2025 08:00 ET | Source: UroGen Pharma Ltd.

UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Findings published in the journal of Clinical Genitourinary Cancer show patients remained event-free for a median of two years after achieving complete response with ZUSDURI (mitomycin) intravesical...
June 05, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
May 15, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
May 13, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
May 01, 2025 08:00 ET | Source: CG Oncology Inc.

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
April 26, 2025 16:10 ET | Source: CG Oncology Inc.

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA
April 24, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025

CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
March 31, 2025 08:00 ET | Source: CG Oncology Inc.

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates

Next Page keyboard_arrow_right